Development of monoclonal antibodies to prevent and treat infections from Flaviviruses[E8]

Dal bando

Call: Cluster 1 - Health (Single stage - 2027/1). Type of action: HORIZON Research and Innovation Actions. Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed at, tailored towards and contributing to all the following expected outcomes: The scientific and clinical communities have a better understanding of and access to experimental monoclonal antibodies for the prevention and treatment of emerging or re-emerging viral infections, as well as for further clinical investigation. Candidate monoclonal antibody therapies are available to treat patients for emerging and re-emerging viral infections, increasing therapeutic options for clinical deployment in case of an epidemic or pandemic. Scope: Infectious diseases remain a major threat to health and health security in the EU and globally. Viral disease emergence is already being accelerated by climate change, and thus a proactive approach to the development of antiviral prophylactics and therapeutics in preparedness for future infectious disease outbreaks is needed. The capacity to produce antibodies that can target new variants and rapidly increase production would serve as an essential preparedness strategy against future health threats, whether from infectious disease epidemics or pandemics. This topic contributes to strengthening the Research and Innovation ecosystem within the EU and supports the imp…[E3]

I dettagli del bando sono mostrati come li ha pubblicati la fonte. I fatti e i requisiti che estraiamo sono scritti in inglese.

• Aperto aUniversities and research. Etichettato da SLETOR in base alle parole del bando.
• CondizioneEU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.[E4]

• RischioThis is a grant, not a contract. Grants usually need a proposal against the funder's criteria, may need partners and often need co-funding.[E5]
• SconosciutoWe read the funder's listing, not the full guidance or application forms.

1. Aperto alle offerte · 29 ott 2026, 07:41 UTC

   The funder published the call with a future closing date.

   Modificato: status, notice type, published at (record di origine Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06))

2. Visto per la prima volta · 28 ott 2026, 21:22 UTC

   The funder announced the call. Applications have not opened yet.

   Record di origine: Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06)

Ogni dato di questa pagina viene dal bando dell'ente. Ogni voce mostra il record e il campo da cui è stato letto.

1. E1

   The funder is European Commission.

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

2. E2

   Proposals must be submitted by 17 Feb 2027, 01:00 Central European time (UTC+1).

   “2027-02-17T00:00:00.000+0000”

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/deadlineDate/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

3. E3

   The buyer describes the requirement in the notice.

   “Expected Outcome: This topic aims at supporting activities that are enabling or contributing to one or several expected impacts of destination “Tackling diseases and reducing disease burden”. To that end, proposals under this topic should aim to deliver results that are directed…”

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/descriptionByte/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

4. E4

   EU grant rules apply: check the call conditions for who can apply, consortium rules and co-funding.

   “EU call topic”

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/type/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

5. E5

   This is an EU call for proposals.

   “31094502”

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

6. E6

   Applications open on 29 Oct 2026.

   “2026-10-29T00:00:00.000+0000”

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/startDate/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

7. E7

   The Funding & Tenders Portal gives the status as open for submission.

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/status/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

8. E8

   The notice is titled "Development of monoclonal antibodies to prevent and treat infections from Flaviviruses".

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/title/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

9. E9

   The EU contribution per grant is up to EUR 11,000,000 (from EUR 3,000,000).

   Da Development of monoclonal antibodies to prevent and treat infections from Flavi… (ID HORIZON-HLTH-2027-01-DISEASE-06), campo /metadata/budgetOverview/0, letto 29 ott 2026, 07:41 UTC · fonte ↗ (si apre in una nuova scheda)

Source: EU Funding & Tenders Portal, © European Union, CC BY 4.0. SLETOR shortened and reformatted the text. Licenza dei dati: Creative Commons Attribution 4.0 (European Commission) ↗ (si apre in una nuova scheda). I recapiti personali presenti nei bandi non vengono conservati né mostrati.